Active surveillance may not be the best option for patients diagnosed with intermediate-risk prostate cancer, results of a prospective study suggest.... More »
A large prospective study found that among 89,918 women aged 50-79 years, bisphosphonate use was inversely associated with age-adjusted endometrial ca... More »
Poor baseline quality-of-life scores were not predictive of worse overall or recurrence-free survival, or of higher risk for adverse events following ... More »
PARIS – Health status should be evaluated when determining how best to treat an older man with prostate cancer, attendees at an international congre... More »
PARIS – Outcomes for women with progressive or relapsed ovarian carcinoma are significantly improving due to the availability of new molecularly tar... More »
Survival rates overall for cancer patients are higher now than 20 years ago, though younger patients are faring significantly better than older ones f... More »
The prevalence of uterine cancer was 0.09% among women who underwent myomectomy with electric power morcellation, according to the results of a large ... More »
Men with favorable intermediate-risk prostate cancer could be considered for active surveillance, say the authors of a study, published in JAMA Oncolo... More »
MAUI, HAWAII – Though costly, newer biologics increase 1-year survival with metastatic melanoma from perhaps 40% to more than 70%.
Among the latest... More »
Adding radiotherapy to androgen-deprivation therapy for locally advanced prostate cancer improves overall survival 30% in the long term, according to ... More »
